Citigroup
GH icon

Citigroup’s Guardant Health GH Stock Holding History

Citigroup’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-147,600
Closed -$3.04M – 5653
2024
Q1 		$3.04M Buy
+147,600
New +$3.16M ﹤0.01% 2075
2023
Q1 		– Sell
-70,000
Closed -$1.9M – 5630
2022
Q4 		$1.9M Sell
70,000
-49,900
-42% -$2.28M ﹤0.01% 2077
2022
Q3 		$6.45M Buy
119,900
+55,600
+86% +$2.85M ﹤0.01% 1395
2022
Q2 		$2.59M Buy
+64,300
New +$3.19M ﹤0.01% 1926
2019
Q4 		– Sell
-20,400
Closed -$1.3M – 7720
2019
Q3 		$1.3M Buy
+20,400
New +$1.8M ﹤0.01% 3339

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citigroup's GH Position: Q2 2026 in Review

Citigroup reduced its Guardant Health (GH) stake by 30% in Q2 2026, selling an estimated $5.74M and leaving 121,338 shares worth $18.2M. The position accounts for 0.01% of the portfolio, ranked #1214.

Citigroup first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $19.3M in Q4 2025. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Citigroup held 121,338 shares of Guardant Health worth $18.2M as of Q2 2026.
  • Citigroup sold 52,734 Guardant Health shares in Q2 2026, an estimated $5.74M.
  • Guardant Health made up 0.01% of Citigroup's portfolio in Q2 2026, its #1214 holding.
  • Citigroup first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
  • Citigroup's Guardant Health position peaked at $19.3M in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.